First Allied Advisory Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
NAM
TRCT
CCP
First Allied Advisory Services's SBIO Position: Q3 2020 in Review
First Allied Advisory Services reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 71% in Q3 2020, selling an estimated $644K and leaving 6,232 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #965.
First Allied Advisory Services first reported a position in SBIO in Q3 2016 and has held it in 11 quarters since. The position peaked at $927K in Q4 2019. 52 funds tracked by Wall St. Rank hold SBIO as of Q3 2020.
- First Allied Advisory Services held 6,232 shares of ALPS Medical Breakthroughs ETF worth $256K as of Q3 2020.
- First Allied Advisory Services sold 15,614 ALPS Medical Breakthroughs ETF shares in Q3 2020, an estimated $644K.
- ALPS Medical Breakthroughs ETF made up 0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #965 holding.
- First Allied Advisory Services first reported a position in ALPS Medical Breakthroughs ETF in Q3 2016 and has held it in 11 quarters since.
- First Allied Advisory Services's ALPS Medical Breakthroughs ETF position peaked at $927K in Q4 2019.
- 52 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2020.
Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.